This free case-based activity includes a crowd-sourced discussion of a 67-year-old Chinese woman who presents at diagnosis with a moderate smoking history of ½ ppd for 15 years presented with episodes of cough, low-grade fever with weight loss in May 2014. Evaluation including a CT chest and PET/CT revealed a 4 cm mass with some bronchial obstruction and associated atelectasis of the lingular portion of the left upper lobe. Pathology showed a NSCLC with squamous differentiation
Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, MOC, completion, or participation certificates for completing this activity.
- Recognize the need for guideline-supported expanded molecular testing, including MET molecular alterations in the management of patients with advanced NSCLC
- List the range of appropriate diagnostic modalities for the assessment of MET molecular alterations including MET exon 14 skipping and MET amplification
- Identify the available treatment options including commercially available and experimental therapies that can be offered for patients identified with MET molecular aberrations
Continuing Education Credit
1 Credit/Point is available for participation in this course. Certificate and credit types available include:
- AMA PRA Category 1 Credits™
- ABIM MOC Points
- CNE Contact Hours
- CPE Credits
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
- Certificate of Completion may be used to document participation, but no credit will be conferred.
- This course expires on March 29, 2020. Participants must complete all necessary course components by this date to receive credit.